3Jayne D,Rasmussen N,Andrassy K,et al.European Vasculitis Study Group:A randomized trial of mainte nance therapy for vasculitis associated with antineutrophil cytoplasmic antibodies[J].N Engl J Med,2003,349:36-44.
4Cattran DC,Appel G,Hebert L,et al.North American Nephrotic Syndrome Study Group Cyclosporine in patients with steroid resistant membranous nephropathy:A randomized trial[J].Kidney Int,2001,59:1484-1490.
5Torres A,Dominguez-Gil B,Carreno A,et al.Conservative versus immuno suppressive treatment of pa tients with idiopathic membranous nephropathy[J].Kidney Int,2002,61:219-227.
6Du Buf-Vereijken PW,Branten AJ.Membranous Nephropathy Study Group.Cytotoxic therapy for membra nous nephropathy and renal insufficiency:Improved renal survival but high relapse rate[J].Nephrol Dial Transplant,2004,19:1142-1148.
7Alexopoulos E,Papagianni A.Treatment of idiopathic membtanous nephropathy[J].Renal Failure,2002,22:697-709.
8Didier D,Catherine BV,Jean-Marc C.Use of pentoxifylline in membtanous nephropathy[J].The lancet,2001,357:1672-1673.
9Ruggenenti P,Chiurchiu C,Brusegan V,et al.Rituximab in idiopathic membranous nephropathy:A oneyear prospective study[J].J Am Soc Nephrol,2003,14:1851-1857.
10Appel G,Nachman P,Hogan S,et al.Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy[J].J Am Soc Nephrol,2002,13::668.
